VERSANT VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GLUE | 5.65M | $41.89M |
 | LENZ | 2.66M | $123.76M |
 | RPTX | 2.65M | $4.66M |
 | SKYE | 2.01M | $7.89M |
 | JBIO | 1.53M | $13.17M |
 | CTNM | 543K | $6.38M |
 | TPST | 270K | $2.77M |
 | CRSP | 149K | $9.65M |
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
5.65M
Value
$41.89M
LENZ Therapeutics, Inc.
LENZ
Shares Held
2.66M
Value
$123.76M
Repare Therapeutics Inc.
RPTX
Shares Held
2.65M
Value
$4.66M
Skye Bioscience, Inc.
SKYE
Shares Held
2.01M
Value
$7.89M
Jade Biosciences, Inc.
JBIO
Shares Held
1.53M
Value
$13.17M
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
543K
Value
$6.38M
Tempest Therapeutics, Inc.
TPST
Shares Held
270K
Value
$2.77M
CRISPR Therapeutics AG
CRSP
Shares Held
149K
Value
$9.65M